Profile data is unavailable for this security.
About the company
EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.
- Revenue in GBP (TTM)50.95m
- Net income in GBP4.78m
- Incorporated2002
- Employees309.00
- LocationEKF Diagnostics Holdings PLCAvon HSE, 19 Stanwell RoadPENARTH CF64 2EZUnited KingdomGBR
- Phone+44 292 071 0570
- Fax+44 292 070 5715
- Websitehttps://www.ekfdiagnostics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANGLE plc | 2.19m | -20.13m | 35.49m | 150.00 | -- | 1.25 | -- | 16.24 | -0.0772 | -0.0772 | 0.0084 | 0.0879 | 0.0539 | 0.3521 | 1.21 | 14,573.33 | -49.68 | -- | -56.03 | -- | 69.90 | -- | -920.95 | -- | 4.95 | -- | 0.1656 | -- | 109.99 | -- | 7.17 | -- | -- | -- |
| Tissue Regenix Group PLC | 23.94m | -828.82k | 43.32m | 76.00 | -- | 1.92 | 1,514.21 | 1.81 | -0.0118 | -0.0118 | 0.3393 | 0.3167 | 0.7061 | 1.33 | 6.41 | 314,953.50 | -2.17 | -13.45 | -2.43 | -14.78 | 49.48 | 45.90 | -3.08 | -28.80 | 1.47 | 0.3716 | 0.263 | -- | 20.50 | 13.75 | 36.44 | -- | 9.78 | -- |
| Inspecs Group PLC | 195.14m | -4.11m | 53.89m | 1.67k | -- | 0.5286 | 6.33 | 0.2761 | -0.0404 | -0.0404 | 1.92 | 1.00 | 0.8667 | 2.31 | 7.65 | 116,640.80 | -1.82 | -1.48 | -2.62 | -2.15 | 51.46 | 48.50 | -2.10 | -1.97 | 0.8696 | 0.6441 | 0.377 | -- | 1.16 | 36.45 | 84.22 | -- | 51.04 | -- |
| SDI Group PLC | 65.85m | 4.23m | 61.69m | 503.00 | 14.68 | 1.36 | 7.49 | 0.9368 | 0.0402 | 0.0402 | 0.6256 | 0.4344 | 0.793 | 0.989 | 5.34 | 130,906.60 | 5.12 | 7.85 | 6.11 | 10.01 | 30.84 | 64.06 | 6.46 | 9.48 | 1.35 | 4.85 | 0.321 | 0.00 | -2.56 | 30.46 | 9.30 | 17.22 | 12.08 | -- |
| Creo Medical Group PLC | 30.80m | -21.70m | 113.06m | 287.00 | -- | 1.89 | -- | 3.67 | -0.0709 | -0.0709 | 0.0984 | 0.1655 | 0.4054 | 1.78 | 4.01 | 107,317.10 | -28.56 | -26.07 | -34.84 | -30.94 | 49.68 | 47.58 | -70.45 | -118.24 | 3.01 | -- | 0.1219 | -- | 13.36 | -- | 19.44 | -- | -- | -- |
| EKF Diagnostics Holdings PLC | 50.95m | 4.78m | 131.58m | 309.00 | 27.57 | 1.91 | 13.16 | 2.58 | 0.0105 | 0.0105 | 0.1123 | 0.1516 | 0.6307 | 3.01 | 6.99 | 160,728.70 | 6.34 | 5.20 | 7.35 | 6.13 | 48.05 | 50.04 | 10.05 | 7.91 | 3.08 | 1,703.50 | 0.0175 | 113.68 | -21.05 | 4.34 | 123.28 | -25.30 | 30.37 | -- |
| Tristel Plc | 39.49m | 6.04m | 190.46m | 213.00 | 31.84 | 6.09 | 22.26 | 4.82 | 0.1256 | 0.1256 | 0.8219 | 0.6567 | 0.992 | 1.51 | 6.26 | 185,394.40 | 15.17 | 8.86 | 17.10 | 10.24 | 82.59 | 80.63 | 15.29 | 10.63 | 3.93 | 411.73 | 0.1605 | 109.99 | 15.70 | 10.14 | 351.98 | 6.40 | 9.88 | 18.05 |
| Advanced Medical Solutions Group plc | 131.11m | 11.13m | 533.32m | 1.50k | 48.03 | 2.20 | 23.74 | 4.07 | 0.051 | 0.051 | 0.6011 | 1.12 | 0.3977 | 1.70 | 4.91 | 154,244.70 | 3.38 | 6.54 | 3.64 | 7.06 | 54.45 | 56.75 | 8.49 | 14.82 | 6.80 | -- | 0.2702 | 25.85 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
| Holder | Shares | % Held |
|---|---|---|
| Harwood Capital LLPas of 22 Mar 2024 | 132.35m | 29.17% |
| Liontrust Investment Partners LLPas of 20 Mar 2024 | 54.42m | 11.99% |
| Gresham House Asset Management Ltd. (Investment Management)as of 20 Mar 2024 | 49.79m | 10.97% |
| Link Fund Solutions Ltd.as of 31 May 2024 | 35.36m | 7.79% |
| Schroder Investment Management Ltd.as of 20 Mar 2024 | 24.51m | 5.40% |
| Octopus Investments Ltd.as of 03 Sep 2024 | 6.14m | 1.35% |
| AXA Investment Managers UK Ltd.as of 03 Sep 2024 | 5.34m | 1.18% |
| Jarvis Investment Management Ltd.as of 03 Sep 2024 | 5.29m | 1.17% |
| Discover Capital GmbHas of 30 Jun 2024 | 5.00m | 1.10% |
| KW Investment Management Ltd.as of 03 Sep 2024 | 3.73m | 0.82% |
